This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
24 Nov 2011

Biocon Launches Haselmeier’s Insulin Pen in India

Biocon has worldwide distribution rights to INSUPen?, for use with Biocon’s insulin and insulin analogues.

Haselmeier has announced that Biocon, one of Asia’s premier biotechnology companies, has launched INSUPen? in India.

 

Under the terms of the agreement between the two companies, Biocon has worldwide distribution rights to INSUPen?, for use with Biocon’s insulin and insulin analogues.

 

The first launch of the INSUPen? has taken place with Biocon’s Basalog? and Insugen? insulins.

 

The INSUPen? is a reusable insulin pen based on Haselmeier’s popular i-pen technology. It is designed to be easy to use for the patient and provide accurate and reliable dosing. The INSUPen? is available in 3 attractive colors and is currently custom designed for use with both Basalog?

Related News